Manchester Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Manchester Capital Management’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-215	Closed	-$1K	–	746
2020 Q3	$1K	Hold	215	–	–	﹤0.01%	494
2020 Q2	$1K	Hold	215	–	–	﹤0.01%	537
2020 Q1	$0	Hold	215	–	–	﹤0.01%	550
2019 Q4	$1K	Buy	+215	New	+$752	﹤0.01%	518

Other funds holding CRVS

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Telemetry Investments New York $42.8M AUM 0.06% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return